|

Two Component Product CLBR001 + ABBV-461 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Calibr, a division of Scripps Research1

Indications

  • Locally Advanced Breast Cancer (LABC)1
  • HER2 + Breast Cancer1
  • Malignant Neoplasm of Breast1
  • Breast Cancer, Metastatic1
  • Triple Negative Breast Cancer (TNBC)1

Augusta, Georgia1 trial

A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

Augusta University Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.